跳至主要内容
临床试验/NCT00410345
NCT00410345已完成4 期

Cervical Rippening With Antiprogesterone in Midtrimester Abortions

Hadassah Medical Organization1 个研究点 分布在 1 个国家目标入组 145 人开始时间: 2004年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
145
试验地点
1
主要终点
success of abortion induction

研究概览

简要总结

Induction of midtrimester abortion includes cervical ripening and then contraction to induce uterine evacuation. There are several protocols, but most of them include using prostaglandins (PG). The disadvantages of using PG include uncomfortable side effects and limits of using it for women after cesarean section. Mifepristone is an antiprogesterone drug and been used for induction of abortion in first and second trimesters abortions. The aim of this study is to explore the effectiveness of Mifepristone for cervical ripening before high dose Oxytocin drip.

详细描述

The aim of this study is to explore the effectiveness of Mifepristone for cervical ripening before high dose Oxytocin drip in midtrimester abortions. After informed consent, all the women will be randomized for Mifepristone or placebo. 48 hours later, high dose oxytocin drip will be started and we will examine the success rate to induce abortion, the duration from starting oxytocin till evacuation of uterus and side effects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • midtrimester late abortion
  • midtrimester induced abortion

排除标准

  • placenta previa
  • infected abortion
  • rupture of membranes
  • s/p cesarean section *2 or more

研究组 & 干预措施

Pitocin

Experimental

Treatment with Pitocin after mifegine

干预措施: Mifepristone (Drug)

Cytotec

Active Comparator

Treatment with cytotec after mifegine

干预措施: Mifepristone (Drug)

结局指标

主要结局

success of abortion induction

abortion induction duration

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验